Literature DB >> 4817870

Current status of bilateral adrenalectomy or advanced prostatic carcinoma.

T Bhanalaph, M J Varkarakis, G P Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4817870      PMCID： PMC1355708          DOI： 10.1097/00000658-197401000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  16 in total

1.  A survey of total adrenalectomy in cancer of the prostate.

Authors:  D A MACFARLANE; L P THOMAS; J H HARRISON
Journal:  Am J Surg       Date:  1960-04       Impact factor: 2.565

2.  Total adrenalectomy for malignant disease of the prostate and breast.

Authors:  J D FERGUSSON
Journal:  Proc R Soc Med       Date:  1954-11

3.  Effect of surgical Addison's disease on advanced carcinoma of the breast and prostate.

Authors:  S G TAYLOR; N ECKLES; D P SLAUGHTER; J H McDONALD
Journal:  Cancer       Date:  1953-09       Impact factor: 6.860

4.  Bilateral adrenalectomy for prostatic cancer.

Authors:  P L SCARDINO; C L PRINCE; T A MCGOLDRICK
Journal:  J Urol       Date:  1953-07       Impact factor: 7.450

5.  Total adrenalectomy for reactivated carcinoma of the prostate.

Authors:  J H HARRISON; G W THORN; D JENKINS
Journal:  N Engl J Med       Date:  1953-01-15       Impact factor: 91.245

6.  Effect of Bilateral Adrenalectomy on Certain Human Tumors.

Authors:  C Huggins; D M Bergenstal
Journal:  Proc Natl Acad Sci U S A       Date:  1952-01       Impact factor: 11.205

7.  Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen.

Authors:  C Huggins; W W Scott
Journal:  Ann Surg       Date:  1945-12       Impact factor: 12.969

8.  Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases.

Authors:  R M NESBIT; W C BAUM
Journal:  J Am Med Assoc       Date:  1950-08-12

9.  Adrenalectomy and hypophysectomy in advanced prostatic carcinoma.

Authors:  G Reynoso; G P Murphy
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

10.  Bilateral adrenalectomy for advanced prostatic carcinoma.

Authors:  R Schoonees; D S Schalch; G Reynoso; G P Murphy
Journal:  J Urol       Date:  1972-07       Impact factor: 7.450
View more
  5 in total

Review 1.  Review of assessment of total androgen blockade as treatment of metastatic prostate cancer.

Authors:  J Geller
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

Review 2.  Hormonal aspects of prostatic cancer: a review.

Authors:  J Waxman
Journal:  J R Soc Med       Date:  1985-02       Impact factor: 5.344

Review 3.  Cholesterol as a potential target for castration-resistant prostate cancer.

Authors:  Alexis L Twiddy; Carlos G Leon; Kishor M Wasan
Journal:  Pharm Res       Date:  2010-08-04       Impact factor: 4.200

4.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

Authors:  R Bruce Montgomery; Elahe A Mostaghel; Robert Vessella; David L Hess; Thomas F Kalhorn; Celestia S Higano; Lawrence D True; Peter S Nelson
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

5.  Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression.

Authors:  Campbell M Grant; Natasha Kyprianou
Journal:  Transl Androl Urol       Date:  2013-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.